FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4251134275> ?p ?o ?g. }

• W4251134275 endingPage "513" @default.
• W4251134275 startingPage "508" @default.
• W4251134275 abstract "We have previously reported that pituitary vasoactive intestinal peptide (VIP) mediates through autoparacrine mechanisms insulin-like growth factor-I and TRH-stimulated PRL release. In the present study, we have investigated whether VIP might also be implicated in the PRL increase that follows dopamine (DA) withdrawal. The experiments were carried out in defined medium supplemented or not with T3, as in a previous study we had found that PRL release increases under low T3 culture conditions due to mediation by concomittant stimulus of VIP. Anterior pituitary (AP) cells from adult male rats were incubated for 1 h in the presence of DA (10 microM), a VIP-receptor antagonist (VIP-At) (200 nM), or DA plus VIP-At. Then media were removed and the cells were washed with PBS and reincubated under the same conditions but without the addition of DA. In the first incubation, DA inhibited PRL release by 80%, and VIP release by 20% in both T3-free and T3 medium. In the second period of incubation, PRL and VIP release were increased in AP cells previously exposed to DA. These effects were greater when the cells were cultured in T3-free medium than in T3-medium (225% and 150%, respectively for PRL release; and 155 and 135%, respectively for VIP release). PRL response to DA withdrawal was inhibited by the simultaneous presence of VIP-At. This inhibition was again greater when the cells were incubated in medium supplemented with T2. Thus, the stimulus of DA withdrawal was inhibited by 88% in T2-free medium and by 37% in T3-medium. To investigate whether pituitary VIP messenger RNA (mRNA) expression is under dopaminergic control, AP cells were incubated in the presence or absence of bromocriptine (BC) (10 nM) for 2 and 24 h. After 24 h of incubation, BC decreased mRNA levels of PRL and of the two transcripts which VIP expresses in AP. As with DA, BC also inhibited PRL and VIP release both at 2 and 24 h. These data demonstrate that VIP, at least partially, mediates DA withdrawal-induced PRL release through an autoparacrine action. They also suggest that simultaneous inhibition of pituitary VIP mRNA expression and VIP release may be a necessary mechanism for the dopaminergic inhibition of PRL mRNA expression and PRL release." @default.
• W4251134275 created "2022-05-12" @default.
• W4251134275 creator A5070832239 @default.
• W4251134275 date "1996-02-01" @default.
• W4251134275 modified "2023-09-25" @default.
• W4251134275 title "Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion" @default.
• W4251134275 doi "https://doi.org/10.1210/en.137.2.508" @default.
• W4251134275 hasPublicationYear "1996" @default.
• W4251134275 type Work @default.
• W4251134275 citedByCount "4" @default.
• W4251134275 crossrefType "journal-article" @default.
• W4251134275 hasAuthorship W4251134275A5070832239 @default.
• W4251134275 hasBestOaLocation W42511342751 @default.
• W4251134275 hasConcept C118303440 @default.
• W4251134275 hasConcept C126322002 @default.
• W4251134275 hasConcept C134018914 @default.
• W4251134275 hasConcept C137183658 @default.
• W4251134275 hasConcept C170493617 @default.
• W4251134275 hasConcept C185592680 @default.
• W4251134275 hasConcept C25642318 @default.
• W4251134275 hasConcept C2779064019 @default.
• W4251134275 hasConcept C49039625 @default.
• W4251134275 hasConcept C513476851 @default.
• W4251134275 hasConcept C55493867 @default.
• W4251134275 hasConcept C71315377 @default.
• W4251134275 hasConcept C71924100 @default.
• W4251134275 hasConcept C8330315 @default.
• W4251134275 hasConcept C86803240 @default.
• W4251134275 hasConceptScore W4251134275C118303440 @default.
• W4251134275 hasConceptScore W4251134275C126322002 @default.
• W4251134275 hasConceptScore W4251134275C134018914 @default.
• W4251134275 hasConceptScore W4251134275C137183658 @default.
• W4251134275 hasConceptScore W4251134275C170493617 @default.
• W4251134275 hasConceptScore W4251134275C185592680 @default.
• W4251134275 hasConceptScore W4251134275C25642318 @default.
• W4251134275 hasConceptScore W4251134275C2779064019 @default.
• W4251134275 hasConceptScore W4251134275C49039625 @default.
• W4251134275 hasConceptScore W4251134275C513476851 @default.
• W4251134275 hasConceptScore W4251134275C55493867 @default.
• W4251134275 hasConceptScore W4251134275C71315377 @default.
• W4251134275 hasConceptScore W4251134275C71924100 @default.
• W4251134275 hasConceptScore W4251134275C8330315 @default.
• W4251134275 hasConceptScore W4251134275C86803240 @default.
• W4251134275 hasIssue "2" @default.
• W4251134275 hasLocation W42511342751 @default.
• W4251134275 hasOpenAccess W4251134275 @default.
• W4251134275 hasPrimaryLocation W42511342751 @default.
• W4251134275 hasRelatedWork W1966296538 @default.
• W4251134275 hasRelatedWork W1983836497 @default.
• W4251134275 hasRelatedWork W1995680439 @default.
• W4251134275 hasRelatedWork W2030613578 @default.
• W4251134275 hasRelatedWork W2062579683 @default.
• W4251134275 hasRelatedWork W2077944812 @default.
• W4251134275 hasRelatedWork W2080277814 @default.
• W4251134275 hasRelatedWork W2088742023 @default.
• W4251134275 hasRelatedWork W2136342712 @default.
• W4251134275 hasRelatedWork W2163744984 @default.
• W4251134275 hasVolume "137" @default.
• W4251134275 isParatext "false" @default.
• W4251134275 isRetracted "false" @default.
• W4251134275 workType "article" @default.